Despite being recognized as one of the most successful public health measures, vaccination is perceived as unsafe and unnecessary by a growing number of individuals. Lack of confidence in vaccines is now considered a threat to the success of vaccination programs. Vaccine hesitancy is believed to be responsible for decreasing vaccine coverage and an increasing…
Human Vaccines & Immunotherapeutics Template
Write in a clean editor, then format for Human Vaccines & Immunotherapeutics in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Human Vaccines & Immunotherapeutics format
Human Vaccines & Immunotherapeutics is a peer-reviewed journal published by Taylor & Francis, covering Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Human Vaccines & Immunotherapeutics 12 (3): 45–58.
Formats any DOI in Human Vaccines & Immunotherapeutics style. No sign-up. |
| Publishes research in | Vaccine Coverage and Hesitancy Influenza Virus Research Studies SARS-CoV-2 and COVID-19 Research Respiratory viral infections research Hepatitis B Virus Studies |
| ISSN | 2164-5515 |
| Citation impact (2-yr) | 3.96 |
| h-index | 130 |
| i10-index | 3,700 |
| Total citations | 152,157 |
| Article processing charge | $3,175 |
| Open access | Yes |
| Top institutions publishing here | GlaxoSmithKline (Belgium) |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Human Vaccines & Immunotherapeutics per year
Citation impact of Human Vaccines & Immunotherapeutics by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Human Vaccines & Immunotherapeutics
Despite major advances in vaccination over the past century, resurgence of vaccine-preventable illnesses has led the World Health Organization to identify vaccine hesitancy as a major threat to global health. Vaccine hesitancy may be fueled by health information obtained from a variety of sources, including new media such as the Internet and social media platforms.…
BACKGROUND: The development of a vaccine against SARS-CoV-2 infection is on the way. To prepare for public availability, the acceptability of a hypothetical COVID-19 vaccine and willingness to pay (WTP) were assessed to provide insights into future demand forecasts and pricing considerations. METHODS: A cross-sectional survey was conducted from 3 to 12 April 2020. The…
To investigate factors associated with intention to be vaccinated against COVID-19 we conducted a cross-sectional survey of 1,500 UK adults, recruited from an existing online research panel. Data were collected between 14th and 17th July 2020. We used linear regression analyses to investigate associations between intention to be vaccinated for COVID-19 "when a vaccine becomes…
studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt…